- CD44/CD24 and aldehyde dehydrogenase 1 in estrogen receptor-positive early breast cancer treated with tamoxifen: CD24 positivity is a poor prognosticator
Yong Wha Moon et al, 2018, Oncotarget CrossRef - Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis
L. Durko et al, 2017, Disease Markers CrossRef - Reliability of CD44, CD24, and ALDH1A1 immunohistochemical staining: Pathologist assessment compared to quantitative image analysis
Lusine Yaghjyan et al, 2022, Frontiers in Medicine CrossRef - Clinical Value of CD24 Expression in Retinoblastoma
Jia Li et al, 2012, Journal of Biomedicine and Biotechnology CrossRef - CD24 blunts oral squamous cancer development and dampens the functional expansion of myeloid-derived suppressor cells
Caroline W. Fugle et al, 2016, OncoImmunology CrossRef - Properties of cancer stem cells
Jacek Wojcierowski et al, 2022, Diagnostyka Laboratoryjna CrossRef